Navigation Links
Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting
Date:12/2/2009

can Society of Hematology Annual Meeting and Exposition, New Orleans, LA. December 5-8, 2009.

(3) Stone, et al. A Phase 1b Study of Midostaurin (PKC412) in Combination with Daunorubicin and Cytarabine Induction and High-Dose Cytarabine Consolidation in Patients Under Age 61 with Newly Diagnosed De Novo Acute Myeloid Leukemia: Overall Survival of Patients Whose Blasts Have FLT3 Mutations is Similar to Those with Wild-Type FLT3. 51st American Society of Hematology Annual Meeting and Exposition, New Orleans, LA. December 5-8, 2009.

(4) Verstovsek, et al. Long-Term Follow Up and Optimized Dosing Regimen of INCB018424 in Patients with Myelofibrosis: Durable Clinical, Functional and Symptomatic Responses with Improved Hematological Safety. 51st American Society of Hematology Annual Meeting and Exposition, New Orleans, LA. December 5-8, 2009.

(5) Verstovsek, et al. A Phase 2 Study of INCB018424, An Oral, Selective JAK1/JAK2 Inhibitor, in Patients with Advanced Polycythemia Vera (PV) and Essential Thrombocythemia (ET) Refractory to Hydroxyurea. 51st American Society of Hematology Annual Meeting and Exposition, New Orleans, LA. December 5-8, 2009.

(6) Pennell, et al. Efficacy and Safety of Deferasirox (Exjade®) in b-Thalassemia Patients with Myocardial Siderosis: 2-Year Results From the EPIC Cardiac Sub-Study. 51st American Society of Hematology Annual Meeting and Exposition, New Orleans, LA. December 5-8, 2009.

(7) San-Miguel, et al. A Phase IB, Multi-Center, Open-Label Dose-Escalation Study of Oral Panobinostat (LBH589) and I.V. Bortezomib in Patients with Relapsed Multiple Myeloma. 51st American Society of Hematology Annual Meeting and Exposition, New Orleans, LA. December 5-8, 2009.

(8) Padmanabhan, et al. A Phase I/II Study of BHQ880, a Novel Osteoblat Activating, Anti-DKK1 Human Monoclonal Antibody, in Relapsed and Refractory Multiple Myeloma (MM) Patients Treated with Zoledronic Acid (Zol) and An
'/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
10. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
11. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015   Intarcia Therapeutics, Inc. ... Brady as Vice President, Human Resources, reporting directly ... CEO. As a new key member of the senior ... CEO and Leadership Team to assure the Company advances ... further embeds its core values and its dynamic culture. ...
(Date:5/1/2015)... , May 01, 2015 Research and Markets ... "Asian Dermatology Devices Market by Type, by End User - ... The Asian Dermatology Devices market is estimated to grow at ... China holds a larger share in the Dermatology ... Japan . The Asian Dermatology Devices market holds a ...
(Date:5/1/2015)... ATLANTA , May 1, 2015 At ... May 2-6 in Washington D.C. , ... a solution that enables clinicians to leverage the enormous ... Knife radiosurgery treatments conducted each year – to advance ... "Gamma Knife Registry is a cloud-based solution that allows ...
Breaking Medicine Technology:Intarcia Appoints James P. Brady Vice President, Human Resources 2Intarcia Appoints James P. Brady Vice President, Human Resources 3Intarcia Appoints James P. Brady Vice President, Human Resources 4Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 2Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 3Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 2Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 3
...  April 18, 2011 Bedford Laboratories™, a division ... announce the addition of Topotecan Hydrochloride for Injection, ... is AP Bioequivalent to the reference listed drug ... GlaxoSmithKline. Topotecan Hydrochloride for Injection is indicated for ...
... Corporation (Nasdaq: LMNX ) today announced that it ... on Monday, May 9, 2011. A press release announcing the ... (Logo:   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Management ... and financial results for the first quarter ended March 31, ...
Cached Medicine Technology:Bedford Laboratories™ to Begin Shipping Topotecan Hydrochloride for Injection, 4mg SD Vial 2Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011 2Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011 3
(Date:5/2/2015)... 02, 2015 With the success that Veatch ... proud to welcome Neida Miranda and Alex Shields to the ... has over 41 years of combined experience working with dentists ... the dental field for 8 years. She was certified ... Texas. Customer service, positive attitude and showing the importance of ...
(Date:5/1/2015)... Turks and Caicos Islands, BWI (PRWEB) May 02, 2015 ... a new website! It is http://www.thevenetiangracebay.com , ... itself, and it incorporates the stunning white and attractive ... to a study of Google, sixty seven percent of ... The study showed that smartphones were used in ...
(Date:5/1/2015)... CA (PRWEB) May 01, 2015 Jusuru ... Award for the successful repositioning of its flagship nutritional ... company brand with a new name, new logo, new ... DSA Ethos Awards are designed to identify and promote ... its best. , “DSA congratulates Jusuru International for ...
(Date:5/1/2015)... Va. (PRWEB) May 01, 2015 The ... nation’s leading nonprofit authority on the use of health ... as a key contributing resource to the United States ... use of electronically readable cards in Medicare. The report, ... and Providers ” was released to the public on ...
(Date:5/1/2015)... 01, 2015 It’s raining bills on Capitol ... proposals to expand federal support for telemedicine. , ... has been working with Congress,” said Jonathan Linkous, CEO of ... the nation is poised to embrace the use of telecommunications ... step in fulfilling ATA’s mission to improve quality, access, equity ...
Breaking Medicine News(10 mins):Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2
... as an injection into the brain of mice, study finds ... further insight into how a health-boosting compound found in red ... , But scientists have only seen the effect in mice ... emerged that consuming red wine or other products made with ...
... diseases, most health professionals do not have access to ... earliest and most infectious stage. A recent survey ... of syphilis appears in the November 15, 2009 issue ... Definitive diagnosis of primary syphilis (the earliest stage ...
... Delhi, Singapore and Washington DC (October 22, 2009) The rates ... 12 are no higher during the Halloween season than at ... published in the September issue of Sexual Abuse: A ... the Association for the Treatment of Sexual Abusers (published by ...
... Studies by researchers at Wake Forest University School ... in immature rats leads to profound, rapid brain injury ... The N-methyl-D-aspartate (NMDA) receptor is activated when ... by brain cells. This allows calcium to enter into ...
... ARBOR, Mich.---Someone healthy enough to work could still cost an ... A new University of Michigan study shows workers ... employers up to $5,867 annually in health care, pharmacy and ... the good news: Companies can stop those chronic health problems ...
... have best chance of success , THURSDAY, Oct. 22 (HealthDay ... which ones offer the best chance of success with in ... process of selecting embryos for implantation in the mother,s womb ... end in IVF failure or multiple pregnancies," Dr. Emre Seli, ...
Cached Medicine News:Health News:Red-Grape Compound May Improve Diabetes 2Health News:Halloween sex offender policies questioned 2Health News:General anesthetics lead to learning disabilities in animal models 2Health News:General anesthetics lead to learning disabilities in animal models 3Health News:Extra care for outwardly healthy workers costs companies millions annually 2Health News:Assessing Embryo Metabolism May Aid IVF Success 2
... Horizon Cardiology Hemo is a comprehensive ... for the cath lab. Patient ... cardiac images and procedural information all ... patient record, eliminating repetitive data entry. ...
... is a patient monitoring system providing real-time ... at the tissue level, reflecting the patients ... low power light and detects light that ... light is guided to the tissue by ...
PowerMed is a billing software....
Protologics Corporation announces ProtoCLAIMS, Web-based electronic claims product that links and reconciles desktop claims with insurance payers who offer direct claims processing....
Medicine Products: